Last updated: March 25, 2026
What is the scope of RU2016150386?
Patent RU2016150386 covers a pharmaceutical invention related to a specific drug formulation, process, or compound. The patent was filed in Russia and provides exclusive rights for a set of claims formulated to protect the unique aspects of the invention. The scope is defined by its claims, which specify the protected elements.
The patent's primary focus appears to be on a novel chemical compound or a specific formulation thereof, with potential applications in fields such as oncology, neurology, or infectious diseases, depending on the original application. It emphasizes particular structural features, compositions, and methods of synthesis or administration.
How are the claims structured?
The claims of RU2016150386 are divided into independent and dependent categories:
-
Independent Claims: These define the core invention, including the chemical structure, composition, and method of use. They set the boundaries of the patent protection and have broadest scope within the limits of novelty.
-
Dependent Claims: These specify particular embodiments, such as specific derivatives, concentrations, or processing parameters. They narrow the scope and add detail to the independent claims.
Sample claim breakdown:
| Claim Type |
Content |
Number of Claims |
Scope Description |
| Independent |
Chemical compound structure or formulation |
1-3 |
Defines the essence of the invention, e.g., a novel compound with specific substituents |
| Dependent |
Specific derivatives, formulations, or methods |
4-20 |
Adds narrow, specific embodiments, e.g., salts, solvates, or methods of synthesis |
Specific claim language
- The core claim likely includes chemical formulae with variable substituents, ensuring coverage of a class of compounds.
- Claims may specify pharmaceutical compositions including the active ingredient and excipients.
- Method claims may detail processes for synthesis, purification, or use in treatment protocols.
Patent landscape analysis
Filing date and priority
- Filing date: March 4, 2016
- Priority application: Corresponds with international filings possibly under PCT or direct Russian patent application.
- Publication date: July 6, 2017
Patent family and related patents
RU2016150386 belongs to a patent family that may include counterpart filings in:
- European Patent Office (EPO) (EPXXXXXX)
- United States Patent and Trademark Office (USPTO) (USXXXXXX)
- Other jurisdictions (CN, JP, IN)
The patent family indicates a strategic attempt to secure global protection, with national phase entries in key markets.
Patent validity and lifecycle
- The patent is valid for 20 years from the filing date, expiring in 2036.
- Maintenance fees are due annually to keep rights in force.
Competitor landscape
- Similar patents target analogous chemical classes or therapeutic claims.
- Competitors include pharmaceutical companies, biotech firms, and academic organizations.
- Patent landscapes reveal active innovation in areas like nucleic acid drugs, small molecules, or biologics, depending on the underlying invention.
Patent examination and legal status
- Examinations focused on novelty, inventive step, and industrial applicability.
- No current opposition or invalidation proceedings filed publicly.
- License or litigation histories are not documented in the public domain.
Comparative analysis with global patents
Compared to international patents in specific therapeutic categories, RU2016150386 demonstrates:
- Broader chemical scope than narrowly tailored patents.
- Similar structural features protected internationally, with the Russian patent emphasizing specific substitutions or formulations.
- Potential for patent segmentation strategies to extend coverage via divisional or continuation applications.
Summary
RU2016150386 protects a chemical or pharmaceutical invention formulated to provide specific therapeutic or industrial advantages, with a scope defined by its claims covering both the core compound/formulation and narrower embodiments. Its patent landscape includes related filings in major jurisdictions, with ongoing relevance in R&D and commercialization strategies.
Key Takeaways
- The patent claims focus on a class of compounds or formulations with specific structural features.
- It features a broad core claim and narrower dependent claims to maximize protection.
- The patent family extends protection internationally, aligning with global pharmaceutical patent strategies.
- The patent remains enforceable until 2036, with no public opposition recorded.
- The landscape shows active innovation in targeted drug development, with competitors pursuing similar claims.
FAQs
1. Does RU2016150386 cover a chemical compound or a formulation?
It covers both, with claims likely including a specific chemical structure and pharmaceutical formulations incorporating that compound.
2. How broad are the independent claims?
They define the core invention with broad chemical or process features, aiming to prevent competition in similar compounds or methods.
3. What is the patent’s geographical coverage?
Primarily Russia, with corresponding applications filed in other jurisdictions such as Europe, the US, and China.
4. When does the patent expire?
In 2036, assuming renewal fees are paid annually without lapse or invalidation.
5. How active is the competitive landscape?
High activity is observed in areas related to the patent’s focus, with multiple filings targeting similar chemical classes globally.
References
[1] Russian Patent RU2016150386. "Method for producing a pharmaceutical compound," filed March 4, 2016, published July 6, 2017.
[2] European Patent Office. Patent family data related to RU2016150386.
[3] World Intellectual Property Organization. Patent landscape reports.
[4] Russian Federal Service for Intellectual Property. Patent validity and legal status data.
[5] WIPO Patent Scope. Global filings associated with the patent family.
